Medical News

RSS

Arkansas House Panel endorses bill requiring inmates to receive HIV test before release

The Arkansas House Public Health, Welfare and Labor Committee on Thursday endorsed an amended version of a bill (HB 1444) that would require inmates in the state's prisons to receive an HIV test before their release, the Arkansas News Bureau reports.

27 Feb 2007

Russia launches five-year, $2.9 billion plan to combat diseases

The Russian government has approved a five-year, $2.9 billion draft program to combat diseases, including HIV/AIDS, in an effort to improve the country's life expectancy, a spokesperson announced on Thursday, the AP/Guardian reports (AP/Guardian, 2/23).

27 Feb 2007

More frequent participation in needle-exchange programs does not increase risk of HIV infection

Contrary to an earlier study, more frequent participation in needle-exchange programs does not increase risk of HIV infection among injection drug users, according to a study published in the February issue of the American Journal of Medicine, Reuters Health reports.

27 Feb 2007

President Bush in weekly radio address promotes proposal to implement standard tax deductions for health insurance coverage

President Bush during his weekly radio address on Saturday promoted his proposal to offer a standard tax deduction for health insurance, Bloomberg/Bergen Record reports.

27 Feb 2007

Enrollment in Medicaid, other public programs increases after enactment of 1996 welfare reform law

The number of U.S. residents who receive cash payments from welfare has decreased since the enactment of a reform law in 1996, but enrollment in other public programs for low-income residents, such as Medicaid, has increased over the same period, according to a recent analysis by the Associated Press, the AP/Contra Costa Times reports.

27 Feb 2007

Defense Secretary Gates announces creation of independent panel to study military health care conditions

Department of Defense Secretary Robert Gates on Friday announced the creation of an independent panel to examine outpatient conditions at Walter Reed Army Medical Center and other military hospitals, the Los Angeles Times reports (Barnes, Los Angeles Times, 2/24).

27 Feb 2007

Governors criticize provisions on SCHIP in fiscal year 2008 budget request from President Bush

A bipartisan group of governors at the National Governors Association winter meeting on Sunday asked Congress to provide $765 million in supplemental funds for SCHIP, the Bergen Record reports (Jackson, Bergen Record, 2/26).

27 Feb 2007

State proposals for universal health insurance unlikely to succeed

Democratic presidential candidate and former Sen. John Edwards (N.C.) recently released a universal health care proposal that incorporates "the bad idea of raising taxes on employers and forcing individuals to purchase insurance," but before "others get carried away with this model, they should take a look at its most recent manifestation in Massachusetts," Sally Pipes, president and CEO of the Pacific Research Institute, writes in a Wall Street Journal opinion piece.

27 Feb 2007

NASA undersea mission to test space medicine concepts

NASA will send a flight surgeon, two astronauts and a Cincinnati doctor under the ocean off the Florida coast May 7-18 to test space medicine concepts and moon-walking techniques. It is the first undersea mission to include a NASA flight surgeon.

26 Feb 2007

DNA 'cages' to deliver drugs

By combining DNA macromolecules with polymers containing iron, molecular 'cages' can be made: porous structures capable of carrying and delivering drugs or DNA-fragments.

26 Feb 2007

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

26 Feb 2007

Stimuvax investigational lung cancer vaccine phase III study starts

Merck KGaA today announced that the first patient has been enrolled in its global Phase III clinical study, START (Stimulating Targeted Antigenic Responses To NSCLC), assessing the efficacy and safety of Stimuvax (BLP25 liposome vaccine) as a potential treatment for patients with unresectable stage III non-small cell lung cancer (NSCLC).

26 Feb 2007